314 related articles for article (PubMed ID: 9988392)
1. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
[TBL] [Abstract][Full Text] [Related]
2. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
[TBL] [Abstract][Full Text] [Related]
3. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
Raivio T; Wikström AM; Dunkel L
Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
[TBL] [Abstract][Full Text] [Related]
4. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
Zacharin M; Sabin MA; Nair VV; Dabadghao P
Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
[TBL] [Abstract][Full Text] [Related]
5. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
6. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
Cisternino M; Manzoni SM; Coslovich E; Autelli M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
[TBL] [Abstract][Full Text] [Related]
7. Constitutional delayed puberty in males and hypogonadotropic hypogonadism: a reliable and cost-effective approach to differential diagnosis.
Martin MM; Martin AL
J Pediatr Endocrinol Metab; 2005 Sep; 18(9):909-16. PubMed ID: 16279369
[TBL] [Abstract][Full Text] [Related]
8. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
[TBL] [Abstract][Full Text] [Related]
9. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
[TBL] [Abstract][Full Text] [Related]
10. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
Boeri L; Capogrosso P; Salonia A
Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
[TBL] [Abstract][Full Text] [Related]
12. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
[TBL] [Abstract][Full Text] [Related]
13. Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism.
Balducci R; Toscano V; Finocchi G; Municchi G; Mangiantini A; Boscherini B
J Endocrinol Invest; 1990 Jan; 13(1):1-7. PubMed ID: 2108196
[TBL] [Abstract][Full Text] [Related]
14. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
Burgués S; Calderón MD
Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism.
Saal W; Happ J; Cordes U; Baum RP; Schmidt M
Fertil Steril; 1991 Aug; 56(2):319-24. PubMed ID: 1906410
[TBL] [Abstract][Full Text] [Related]
17. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
18. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
20. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
